Table 1 Population descriptors (n = 298)

Age, years, mean ± SD

51 ± 13

Gender, male, number (%)

181 (60.7%)

Regraft, number (%)

29 (9.0%)

Diabetes mellitus, number (%)

69 (23%)

End-stage renal disease

Polycystic kidney disease, number (%)

55 (19%)

Glomerulonephritis, number (%)

85 (29%)

Diabetes mellitus, number (%)

50 (17%)

Recipient weight, kg, mean ± SD

78 ± 17

Recipient body mass index, kg/m², mean ± SD

28 ± 5

Blood transfusion, never, number (%)

205 (69%)

Human leukocyte antigen mismatch, mean ± SD

4.1 ± 1.4

Dialysis duration, days, median (IQR)

819 (419, 1462)

Calculated panel reactive antibody, %, median (IQR)

0 (0, 8)

Cold ischemic time, hours, median (IQR)

12 (8, 16)

Anastamosis time, minutes, median (IQR)

30 (24, 45)

Donation after circulatory death, number (%)

16 (5.4%)

Donor cause of death

Anoxia, number (%)

24 (8%)

Cerebrovascular event, number (%)

189 (62%)

Donor age years, mean ± SD

47 ± 17

Donor male, number (%)

135 (45%)

Donor weight kg, mean ± SD

76 ± 19

Donor body mass index kg/m², mean ± SD

27 ± 6

Donor creatinine μmol/L, mean ± SD

67 ± 31

Delayed graft function, number (%)

56 (18.8%)

Days in hospital, days, median (IQR)

9 (7, 14)

Creatinine day 7, μmol/L, median (IQR)

168 (125, 314)